This treatment also enhanced the clearance of neutrophils/T-cells, improved the ability of CF airway macrophages to kill Pa and lowered the secretion of pro-inflammatory cytokines IL-8 and IL-6 [105]. The gene discussed is CXCL8; the disease is cystic fibrosis.